Anti-CBLC antibody
Product Name Anti-CBLC antibody
Catalog No PAab01319
Packing 100ug
Form liquid
Alternative Name CBL3 antibody, RNF57
Purification Immunogen affinity purified
Purity 95% as determined by SDS-PAGE
Host Rabbit
Isotype IgG
Storage PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20Centigrade for 24 months (Avoid repeated freeze / thaw cycles.)
Background/ FUNCTION
Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Functionally coupled with the E2 ubiquitin-protein ligases UB2D1, UB2D2 and UB2D3. Regulator of EGFR mediated signal transduction; upon EGF activation, ubiquitinates EGFR. Isoform 1, but not isoform 2, inhibits EGF stimulated MAPK1 activation. Promotes ubiquitination of SRC phosphorylated at 'Tyr-419'. In collaboration with CD2AP may act as regulatory checkpoint for Ret signaling by modulating the rate of RET degradation after ligand activation; CD2AP converts it from an inhibitor to a promoter of RET degradation; the function limits the potency of GDNF on neuronal survival.
Immunogen Cas-Br-M (murine) ecotropic retroviral transforming sequence c
Specificity Human,Mouse ,Rat
Tested Application ELISA,WB
Recommended dilution
IHC use
WB use
Protein Information
Gene ID23624
Uniprot ID Q9ULV8
Calculated MW
location
Technical Principle & Methodology
The quality assurance and experimental performance of this biological reagent are rigorously optimized and standardized according to its specific technical pathway:
Immunoglobulin Enzyme Conjugation and Signal Amplification Cascade
(免疫球蛋白酶标偶联与分子信号级联放大技术). This ensures maximum reproducibility across clinical research and scientific workflows.